Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial

P. Sonneveld, I.G.H. Schmidt-Wolf, B. van der Holt, L. El Jarari, U. Bertsch, H. Salwender, S. Zweegman, E. Vellenga, A. Broyl, I.W. Blau, K.C. Weisel, S. Wittebol, G.M.J. Bos, M. Stevens-Kroef, C. Scheid, M. Pfreundschuh, D. Hose, A. Jauch, H. van der Velde, R. RaymakersM.R. Schaafsma, M.J. Kersten, M. van Marwijk-Kooy, U. Duehrsen, W. Lindemann, P.W. Wijermans, H.M. Lokhorst, H.M. GoldschmidtShow 8 moreShow less